Genotypes of chronic progressive external ophthalmoplegia in a large adult-onset cohort.


Journal

Mitochondrion
ISSN: 1872-8278
Titre abrégé: Mitochondrion
Pays: Netherlands
ID NLM: 100968751

Informations de publication

Date de publication:
11 2019
Historique:
received: 12 04 2018
revised: 28 03 2019
accepted: 11 09 2019
pubmed: 16 9 2019
medline: 7 5 2020
entrez: 16 9 2019
Statut: ppublish

Résumé

Chronic progressive external ophthalmoplegia (CPEO) is a common presentation of mitochondrial disease. We performed a retrospective evaluation of the molecular genetic testing and genotype-phenotype correlations in a large cohort of adult-onset CPEO patients (N = 111). One hundred percent of patients tested had at least one mitochondrial DNA (mtDNA) deletion. Genetic testing of nuclear genes encoding mitochondrial proteins identified pathogenic/likely pathogenic variants likely to be associated with CPEO in 7.6% of patients. As expected, the nuclear gene most associated with DNA variation was POLG. A single likely pathogenic mitochondrial DNA variant (m.12278T>C) was identified in two unrelated patients. No significant differences were noted in the clinical phenotypes of patients with pathogenic or likely pathogenic nuclear variants in comparison to those with negative nuclear gene testing. Analysis of deletion size and heteroplasmy in muscle-derived mtDNA showed significant correlations with age of symptom onset but not disease severity (number of canonical CPEO features). Results suggest that smaller mtDNA deletions (p = 0.0127, r

Identifiants

pubmed: 31521625
pii: S1567-7249(18)30096-5
doi: 10.1016/j.mito.2019.09.002
pii:
doi:

Substances chimiques

DNA, Mitochondrial 0
DNA Polymerase gamma EC 2.7.7.7
POLG protein, human EC 2.7.7.7

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

227-231

Subventions

Organisme : CIHR
ID : 143325
Pays : Canada

Informations de copyright

Copyright © 2019 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Auteurs

Julia N Heighton (JN)

Department of Pediatrics, McMaster University, Hamilton, ON, Canada.

Lauren I Brady (LI)

Department of Pediatrics, McMaster University, Hamilton, ON, Canada.

Bekim Sadikovic (B)

Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada; Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, ON, Canada.

Dennis E Bulman (DE)

Newborn Screening Ontario and CHEO Research Institute, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.

Mark A Tarnopolsky (MA)

Department of Pediatrics, McMaster University, Hamilton, ON, Canada. Electronic address: tarnopol@mcmaster.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH